David Qualls, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Genmab
    Topic:
    Epcoritamab
    Date added:
    01/21/2026
    Date updated:
    01/21/2026
    Relationship end date:
    03/19/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    ADC Therapeutics
    Topic:
    Loncastuximab tesirine
    Date added:
    01/21/2026
    Date updated:
    01/21/2026
    Relationship end date:
    11/16/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Kite Pharma
    Topic:
    Practices in CAR T therapy
    Date added:
    01/21/2026
    Date updated:
    01/21/2026
    Relationship end date:
    06/01/2026
Return to 8th Annual UK Healthcare Markey Cancer Center Review of Hematology and Immunotherapy